OPERA Trademark

Trademark Overview

On Thursday, September 10, 2020, a trademark application was filed for OPERA with the United States Patent and Trademark Office. The USPTO has given the OPERA trademark a serial number of 90171690. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by Korro Bio, Inc.. The OPERA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical products; research and development in the field of bioscience; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; research and development of pharmaceutical preparations for the treatment of liver-based disorders, eye disorders and CNS disorders; research and development of oligonucleotide compounds for targeted RNA editing; research and development of oligonucleotide drug platforms for use in the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders
opera

General Information

Serial Number90171690
Word MarkOPERA
Filing DateThursday, September 10, 2020
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7502583
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesResearch and development of pharmaceutical products; research and development in the field of bioscience; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; research and development of pharmaceutical preparations for the treatment of liver-based disorders, eye disorders and CNS disorders; research and development of oligonucleotide compounds for targeted RNA editing; research and development of oligonucleotide drug platforms for use in the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 16, 2020
Primary Code042
First Use Anywhere DateSunday, November 29, 2020
First Use In Commerce DateSunday, November 29, 2020

Trademark Owner History

Party NameKorro Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameKorro Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameKorro Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, September 14, 2020NEW APPLICATION ENTERED
Friday, October 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 21, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021NON-FINAL ACTION WRITTEN
Thursday, January 28, 2021NON-FINAL ACTION E-MAILED
Thursday, January 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 9, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 9, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, March 9, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 9, 2021ASSIGNED TO LIE
Tuesday, March 9, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, March 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 30, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 30, 2021SOU EXTENSION 1 FILED
Tuesday, November 30, 2021SOU EXTENSION 1 GRANTED
Thursday, December 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 3, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 3, 2022SOU EXTENSION 2 FILED
Friday, June 3, 2022SOU EXTENSION 2 GRANTED
Tuesday, June 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 28, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 28, 2022SOU EXTENSION 3 FILED
Monday, November 28, 2022SOU EXTENSION 3 GRANTED
Wednesday, November 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 31, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2023SOU EXTENSION 4 FILED
Wednesday, May 31, 2023SOU EXTENSION 4 GRANTED
Friday, June 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023SOU EXTENSION 5 FILED
Wednesday, November 29, 2023SOU EXTENSION 5 GRANTED
Thursday, November 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 7, 2024TEAS STATEMENT OF USE RECEIVED
Friday, June 7, 2024USE AMENDMENT FILED
Monday, July 22, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 23, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 8, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, April 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 3, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 3, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

opera disorders diseases research development oligonucleotide liver pharmaceutical treatment rare genetic